Nan Ji is the founder of PAQ Therapeutics. PAQ Therapeutics has raised $30M in total funding. Latest round: Series A. Based in Burlington, United States.
Nan Ji is the Co-founder, President, and CEO of PAQ Therapeutics, a clinical-stage biotechnology company focused on autophagy-based drug degraders. Before co-founding PAQ in 2020, he spent seven years at Novartis and was VP of Chemistry at Kymera Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library